Description
HPG.CE: HP IgG – ELISA
Enzyme ImmunoAssay (ELISA) for the quantitative/qualitative determination of IgG antibodies to Helicobacter pylori in human plasma and sera. The product is intended for the follow-up of patients showing gastrointestinal pathologies potentially correlated to HP infection. For “in vitro” diagnostic use only.
Microplates are coated with H.pylori immunodominant antigens derived from tissue culture of a virulent strain. In the 1st incubation, the solid phase is treated with diluted samples and anti-HP IgG are captured, if present, by the antigens.
HPM.CE: HP IgM – ELISA
Enzyme ImmunoAssay (ELISA) for the determination of IgM antibodies to Helicobacter pylori in human plasma and sera. For “in vitro” diagnostic use only.
Microplates are coated with H.pylori immunodominant antigens derived from tissue culture of a virulent strain. In the 1st incubation, the solid phase is treated with diluted samples and anti-HP IgM are captured, if present, by the antigens.
HPA.CE: HP IgA – ELISA
Enzyme ImmunoAssay (ELISA) for the quantitative/qualitative determination of IgA antibodies to Helicobacter pylori in human plasma and sera.
The product is intended for the follow-up of patients showing gastrointestinal pathologies referable to H.pylori infection. For “in vitro” diagnostic use only. Microplates are coated with H.pylori immunodominant antigens derived from tissue culture of a virulent strain. In the 1st incubation, the solid phase is treated with diluted samples and anti-HP IgA are captured, if present, by the antigens. After washing out all the other components of the sample, in the 2nd incubation bound anti-HP IgA are detected by the addition of anti hIgA antibody, labeled with peroxidase (HRP).
CAGA.CE: HP CagA IgA – ELISA
Enzyme Immunoassay for the quantitative determination of IgA antibodies to Helicobacter pylori cytotoxin associated gene A Antigen or CagA-Ag in sera/plasma. The product is intended for the follow-up of patients showing gastrointestinal pathologies referable to H.pylori infection. For “in vitro” diagnostic use only.
Microplates are coated with Helicobacter pylori specific CagA-Ag synthetic antigen. In the 1st incubation, the solid phase is treated with diluted samples and anti CagA-Ag IgA are captured, if present, by the antigens.
CAGG.CE: HP CagA IgG – ELISA
Enzyme Immunoassay for the quantitative determination of IgG antibodies to Helicobacter pylori cytotoxin associated gene A Antigen or CagA-Ag in sera/plasma. The product is intended for the follow-up of patients showing gastrointestinal pathologies referable to H.pylori infection. For “in vitro” diagnostic use only.
Microplates are coated with Helicobacter pylori specific CagA-Ag synthetic antigen. In the 1st incubation, the solid phase is treated with diluted samples and anti CagA-Ag IgG are captured, if present, by the antigens.
HPAG.CE: HP Ag – ELISA
Enzyme Immunoassay (ELISA) for the one-step qualitative/quantitative determination of Helicobacter pylori Antigen (HP Ag) in human stools. The kit may be used for the the follow-up of HP-infected patients and their pharmacological treatment. For “in vitro” diagnostic use only.
Stools from patients are used as a source of sample for the determination of HP antigen. Microplates are coated with a cocktail of affinity purified mouse monoclonal antibodies directed to the most specific Helicobacter pylori antigens.
In the 1st incubation, the solid phase is treated with the sample, previously extracted from stools, and simultaneously with a mixture of monoclonal antibodies to Hp, conjugated with peroxidase (HRP).
After washing out all the other components of the sample, in the 2nd incubation the bound enzyme specifically present on the solid phase generates an optical signal that is proportional to the amount of H.pylori antigens present in the sample.
